Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-03-07

Clinical Trial Update: Safety and Efficacy of Liraglutide in Parkinson's Disease [Phase 2]

View source ↗

Summary

Phase 2 trial update on safety and efficacy of liraglutide in Parkinson's disease; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • liraglutide (liraglutide)

Snippet

Sponsor: Cedars-Sinai Medical Center | Conditions: Parkinson Disease | Phase 2 | Status: COMPLETED | Results posted: 2024-03-07